Literature DB >> 1955168

Ion exchange chromatography of purified colonic mucus glycoproteins in inflammatory bowel disease: absence of a selective subclass defect.

A Raouf1, N Parker, D Iddon, S Ryder, B Langdon-Brown, J D Milton, R Walker, J M Rhodes.   

Abstract

Previous reports of a selective mucin subclass defect in ulcerative colitis have been reassessed using high performance chromatography (Superose 6 and Mono Q) for mucin purification and fractionation coupled with analysis of the fractions obtained using a combination of enzyme linked lectin and mucin antibody assays. Mucin samples purified from snap frozen rectal biopsy specimens obtained from patients with ulcerative colitis (n = 12), Crohn's disease (n = 5), and non-inflammatory bowel disease control subjects (n = 9) were subject to ion exchange chromatography using a continuous 0-0.35 mol/l NaCl salt gradient with a final 2.5 mol/l NaCl step. In all samples the major proportion (mean (SD) 86.7 (8.9)%) of the mucin detectable by wheat germ agglutinin binding eluted between 0.15 and 0.35 mol/l NaCl with no significant difference in elution profile between ulcerative colitis and control subjects. Significant elution of glycoprotein at less than 0.15 mol/l NaCl did occur, however, when a lower molecular weight mucin containing fraction which contained concanavalin A positive (glucose or mannose containing) material was analysed similarly. Similar ion exchange profiles were obtained when (3H)N-acetylglucosamine labelled mucins were studied after tissue culture of rectal biopsy specimens. No significant alteration in the ion exchange profile of purified mucins in ulcerative colitis has been shown in these studies. It is possible that the previously reported relative depletion of mucin subclass IV (eluting with 0.20 mol/l NaCl) may simply have reflected mucin depletion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1955168      PMCID: PMC1379374          DOI: 10.1136/gut.32.10.1139

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  25 in total

1.  A histochemical comparison of the O-acylated sialic acids of the epithelial mucins in ulcerative colitis, Crohn's disease, and normal controls.

Authors:  C F Culling; P E Reid; W L Dunn
Journal:  J Clin Pathol       Date:  1979-12       Impact factor: 3.411

2.  Composition of human colonic mucin. Selective alteration in inflammatory bowel disease.

Authors:  D K Podolsky; K J Isselbacher
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

3.  Purification and composition of colonic epithelial mucin.

Authors:  J T LaMont; A S Ventola
Journal:  Biochim Biophys Acta       Date:  1980-11-20

4.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

5.  Histochemical demonstration of desialation and desulphation of normal and inflammatory bowel disease rectal mucus by faecal extracts.

Authors:  J M Rhodes; R R Black; R Gallimore; A Savage
Journal:  Gut       Date:  1985-12       Impact factor: 23.059

6.  Mucin degradation in human colon ecosystems. Fecal population densities of mucin-degrading bacteria estimated by a "most probable number" method.

Authors:  R S Miller; L C Hoskins
Journal:  Gastroenterology       Date:  1981-10       Impact factor: 22.682

7.  Glycoprotein composition of colonic mucosa. Specific alterations in ulcerative colitis.

Authors:  D K Podolsky; K J Isselbacher
Journal:  Gastroenterology       Date:  1984-11       Impact factor: 22.682

8.  Abnormal goblet cell glycoconjugates in rectal biopsies associated with an increased risk of neoplasia in patients with ulcerative colitis: early results of a prospective study.

Authors:  C R Boland; P Lance; B Levin; R H Riddell; Y S Kim
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

9.  Regional distribution and alterations of lectin binding to colorectal mucin in mucosal biopsies from controls and subjects with inflammatory bowel diseases.

Authors:  L R Jacobs; P W Huber
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

10.  Monoclonal antibodies raised to colorectal carcinoma antigens.

Authors:  C A Makin
Journal:  Ann R Coll Surg Engl       Date:  1986-11       Impact factor: 1.891

View more
  13 in total

1.  Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients.

Authors:  K Bodger; J Halfvarson; A R Dodson; F Campbell; S Wilson; R Lee; E Lindberg; G Järnerot; C Tysk; J M Rhodes
Journal:  Gut       Date:  2006-02-04       Impact factor: 23.059

2.  Characterization of mucin in whole-gut lavage fluid obtained from patients with inflammatory bowel disease.

Authors:  H Saitoh; K Takagaki; T Nakamura; A Munakata; Y Yoshida; M Endo
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

3.  Colonic mucins in ulcerative colitis: evidence for loss of sulfation.

Authors:  A P Corfield; N Myerscough; N Bradfield; C do A Corfield; M Gough; J R Clamp; P Durdey; B F Warren; D C Bartolo; K R King; J M Williams
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

4.  Altered expression of mucins throughout the colon in ulcerative colitis.

Authors:  J E Smithson; A Campbell; J M Andrews; J D Milton; R Pigott; D P Jewell
Journal:  Gut       Date:  1997-02       Impact factor: 23.059

5.  Stress proteins in colorectal mucosa. Enhanced expression in ulcerative colitis.

Authors:  V R Winrow; G M Mojdehi; S D Ryder; J M Rhodes; D R Blake; D S Rampton
Journal:  Dig Dis Sci       Date:  1993-11       Impact factor: 3.199

6.  Distribution of O-acetylated sialomucin in the normal and diseased gastrointestinal tract shown by a new monoclonal antibody.

Authors:  J D Milton; D Eccleston; N Parker; A Raouf; C Cubbin; J Hoffman; C A Hart; J M Rhodes
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

Review 7.  Intestinal barrier in inflammatory bowel disease.

Authors:  Lena Antoni; Sabine Nuding; Jan Wehkamp; Eduard F Stange
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

8.  Colonic mucin synthesis is increased by sodium butyrate.

Authors:  I A Finnie; A D Dwarakanath; B A Taylor; J M Rhodes
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

9.  Influence of inflammatory bowel disease on the distribution and concentration of pancreatic secretory trypsin inhibitor within the colon.

Authors:  R J Playford; A M Hanby; K Patel; J Calam
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

Review 10.  Altered glycosylation in inflammatory bowel disease: a possible role in cancer development.

Authors:  B J Campbell; L G Yu; J M Rhodes
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.